Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Product sales, net $ 53,696 $ 48,244
Cost of goods sold 18,608 14,366
Gross profit 35,088 33,878
Operating expenses:    
Research and development 5,877 1,885
Selling, general and administrative 46,451 21,746
Total Operating Expenses 52,328 23,631
Operating income (loss) (17,240) 10,247
Interest (income) expense, net (15) 153
Income (loss) before income taxes (17,225) 10,094
Income tax (benefit) expense (615) 93
Net income (loss) $ (16,610) $ 10,001
Weighted average common shares outstanding for basic (shares) 97,861 91,916
Weighted average common shares outstanding for diluted (shares) 97,861 114,470
Net income (loss) per common share    
Basic (in USD per share) $ (0.17) $ 0.11
Diluted (in USD per share) $ (0.17) $ 0.09